# Early phase 1 disease trials recruiting: 55 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 55 trials in early phase 1 for disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Early phase 1 disease trials: 55 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/early-phase-1/disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 55
- Recruiting or not yet: 55
- Read on: November 19, 2026

## Trials

The 25 newest of 55, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07911670 | Exploratory Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease | The First Affiliated Hospital of Anhui Medical University | Early phase 1 | Recruiting | PARKINSON DISEASE (Disorder) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911670) |
| September 29, 2026 | NCT07845825 | Aprepitant for the Treatment of CLIFAHDD | The University of Texas Health Science Center at San Antonio | Early phase 1 | Recruiting | CLIFAHDD, Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay, NALCN Channelopathy... | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845825) |
| September 22, 2026 | NCT07835308 | Bayesian Optimization of DBS for Gait | University of Minnesota | Early phase 1 | Recruiting | Parkinson Disease (PD) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835308) |
| September 8, 2026 | NCT07806045 | Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement | Sponsor not shown (see the record) | Early phase 1 | Not yet recruiting | IgG4 Related Disease, Systemic Sclerosis (SSc) | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806045) |
| July 6, 2026 | NCT07685444 | A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of... | Lingyi Biotech Co., Ltd. | Early phase 1 | Not yet recruiting | Parkinson's Disease (PD) | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07685444) |
| June 10, 2026 | NCT07640555 | Evaluation of \[¹⁸F\]MODAG-009 PET Imaging in Synucleinopathies | MODAG GmbH | Early phase 1 | Recruiting | Multiple System Atrophy (MSA), Healthy Adult, Parkinson Disease | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07640555) |
| June 10, 2026 | NCT07640542 | Test-retest Trial With \[11C\]MODAG-005 in PD or MSA and AMHC - Pilot Phase | MODAG GmbH | Early phase 1 | Recruiting | Parkinson Disease (PD), MSA - Multiple System Atrophy, Healthy Adult Participants | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07640542) |
| June 1, 2026 | NCT07617688 | Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of \[18F\]MODAG-009 Positron Emission Tomography (PET)... | MODAG GmbH | Early phase 1 | Recruiting | Healthy Adult | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617688) |
| April 16, 2026 | NCT07533591 | Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus | Second Affiliated Hospital, Zhejiang University, School of Medicine | Early phase 1 | Not yet recruiting | Parkinson's Disease (PD) | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533591) |
| February 12, 2026 | NCT07407634 | A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects. | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Early phase 1 | Not yet recruiting | Non-Alcoholic Fatty Liver Disease | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07407634) |
| January 12, 2026 | NCT07333677 | In Vivo CAR-T for Refractory Graves' Disease | Shanghai Zhongshan Hospital | Early phase 1 | Recruiting | Graves' Disease | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07333677) |
| January 7, 2026 | NCT07323927 | Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease | Xuanwu Hospital, Beijing | Early phase 1 | Recruiting | Alzheimer Disease | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07323927) |
| December 30, 2025 | NCT07309744 | Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Early phase 1 | Not yet recruiting | Moderate-to-severe Ulcerative Colitis, Crohn's Disease (CD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07309744) |
| December 30, 2025 | NCT07308808 | Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation | Medstar Health Research Institute | Early phase 1 | Recruiting | Spinal Cord Injuries (SCI), Neurogenic Bladder, Urinary Tract Infection (Diagnosis) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07308808) |
| December 23, 2025 | NCT07298590 | An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related... | Changhai Hospital | Early phase 1 | Not yet recruiting | IgG4 Related Disease | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298590) |
| December 9, 2025 | NCT07273188 | 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease | Mayo Clinic | Early phase 1 | Recruiting | Crohn's Disease, Intestinal Fibrosis, Inflamatory Bowel Disease, Intestinal Strictures Related to Crohn´s Disease | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07273188) |
| December 3, 2025 | NCT07261345 | Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease | Shanghai Zhongshan Hospital | Early phase 1 | Recruiting | Graves' Disease | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07261345) |
| October 9, 2025 | NCT07214974 | Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. | Noah Tech, Corp. | Early phase 1 | Not yet recruiting | Mild Cognitive Impairment (MCI), Early Stages of Cognitive Decline, Alzheimer's Disease Dementia, Alzheimer's Disease... | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07214974) |
| October 6, 2025 | NCT07208344 | Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease | Anhui Provincial Hospital | Early phase 1 | Recruiting | Alzheimer Disease (AD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07208344) |
| October 2, 2025 | NCT07203404 | A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. | Nanjing Bioheng Biotech Co., Ltd. | Early phase 1 | Recruiting | SLE, LN, ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis, Anti-GBM Disease, MN, SSc, IIM, IgA Nephropathy | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07203404) |
| September 30, 2025 | NCT07198516 | The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver: | Fujian Medical University Union Hospital | Early phase 1 | Not yet recruiting | NAFLD, Diabete Type 2 | 149 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07198516) |
| September 29, 2025 | NCT07197749 | Vitamin C With Steroids for Gastrointestinal GVHD | Baylor College of Medicine | Early phase 1 | Not yet recruiting | Graft-versus-host-disease (GVHD), Gastrointestinal | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07197749) |
| August 19, 2025 | NCT07129642 | Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease | Shanghai Zhongshan Hospital | Early phase 1 | Recruiting | Graves Disease | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07129642) |
| July 25, 2025 | NCT07085195 | A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease | Ruijin Hospital | Early phase 1 | Not yet recruiting | Parkinson Disease (PD), Gene Therapy, Safety and Efficacy, Clozapine | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07085195) |
| July 14, 2025 | NCT07063251 | An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease | HuidaGene Therapeutics Co., Ltd. | Early phase 1 | Recruiting | Stargardt Disease Type 1 (STGD1) | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07063251) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| MODAG GmbH | 3 |
| Xuanwu Hospital, Beijing | 3 |
| Massachusetts General Hospital | 3 |
| Shanghai Zhongshan Hospital | 3 |
| Tongji Hospital | 3 |
| University of Alabama at Birmingham | 2 |
| University of Minnesota | 2 |
| AC Immune SA | 2 |
| University of Pennsylvania | 2 |
| Anhui Provincial Hospital | 2 |
| University of Nicosia | 1 |
| Nanjing Bioheng Biotech Co., Ltd. | 1 |
| Changhai Hospital | 1 |
| Ruijin Hospital | 1 |
| University of Nebraska | 1 |
| University of California, Los Angeles | 1 |
| Stanford University | 1 |
| Peking University Third Hospital | 1 |
| Children's Hospital of Fudan University | 1 |
| Milton S. Hershey Medical Center | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| University of Texas at Austin | 1 |
| Medstar Health Research Institute | 1 |
| Fujian Medical University Union Hospital | 1 |
| Johns Hopkins University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 23 |
| China | 23 |
| Cyprus | 1 |
| Sweden | 1 |
| Belgium | 1 |
| Netherlands | 1 |
| Germany | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Breweries in the United States](https://specstream.ai/data/businesses/breweries/united-states)
- [B2B signage companies in the United States](https://specstream.ai/data/businesses/b2b-signage-companies/united-states)
- [Australian restaurants in the United States](https://specstream.ai/data/businesses/australian-restaurants/united-states)
- [Adult education centers in the United States](https://specstream.ai/data/businesses/adult-education-centers/united-states)
- [Vocational and technical schools in the United States](https://specstream.ai/data/businesses/vocational-and-technical-schools/united-states)
- [Tools wholesalers in the United States](https://specstream.ai/data/businesses/tools-wholesalers/united-states)
